TerraPower to build $450M Philly manufacturing plant for cancer radiation therapy.
Article excerpt
Highlighted: the sentence this signal was extracted from
TerraPower to build $450M Philly manufacturing plant for cancer radiation therapy. The Bill Gates-backed company is planning a 250,000-square-foot Bellwether District facility to produce actinium-225, a rare isotope used in nuclear medicine. TerraPower Isotopes announced plans to build a $450 million manufacturing facility in Philadelphia's Bellwether District on Tuesday. The Bill Gates-owned nuclear science company will use the site to produce actinium-225, a radioactive isotope used to develop radiation treatments for diseases like leukemia, melanoma and other cancers. After looking at over 350 potential locations, TerraPower selected a 250,000-square-foot space at the Bellwether district because of its proximity to Philly's wider life sciences ecosystem and its capacity for scale, according to a press release. "This new facility is a testament to the demand for actinium-225 as part of the growing industry which is transforming how cancer is treated," said Scott Claunch, president of TerraPower Isotopes. "Our team is proud to be building a large-scale... manufacturing facility in Philadelphia, which will play a pivotal role in expanding global access to this rare isotope." The Pennsylvania government is also investing $10 million into the project, including a $7 million grant through the Pennsylvania Strategic Investments to Enhance Sites program, and a $3 million...
Keep reading with a free account
The rest of this article, and every signal for TerraPower, is in your free account.
